Martin L. Read

3.4k total citations
65 papers, 2.7k citations indexed

About

Martin L. Read is a scholar working on Molecular Biology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Martin L. Read has authored 65 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 24 papers in Genetics and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Martin L. Read's work include RNA Interference and Gene Delivery (28 papers), Virus-based gene therapy research (20 papers) and Advanced biosensing and bioanalysis techniques (17 papers). Martin L. Read is often cited by papers focused on RNA Interference and Gene Delivery (28 papers), Virus-based gene therapy research (20 papers) and Advanced biosensing and bioanalysis techniques (17 papers). Martin L. Read collaborates with scholars based in United Kingdom, United States and Italy. Martin L. Read's co-authors include Leonard W. Seymour, Stephen Neidle, Ann Logan, Margreet A. Wolfert, Philip R. Dash, L B Barrett, David Oupický, Kevin Docherty, Christopher M. Ward and Anthony P. Reszka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Martin L. Read

64 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin L. Read United Kingdom 25 2.2k 801 351 277 265 65 2.7k
Maria Frank-Kamenetsky United States 11 1.9k 0.9× 309 0.4× 163 0.5× 513 1.9× 352 1.3× 16 2.8k
Anja Zeigerer Germany 20 2.2k 1.0× 236 0.3× 161 0.5× 533 1.9× 230 0.9× 29 3.1k
Cindy A. Sprecher United States 22 1.3k 0.6× 205 0.3× 265 0.8× 268 1.0× 306 1.2× 29 2.3k
Irina U. Agoulnik United States 27 1.2k 0.6× 850 1.1× 241 0.7× 95 0.3× 309 1.2× 62 2.4k
Kei‐ichi Ozaki Japan 24 1.2k 0.6× 192 0.2× 83 0.2× 200 0.7× 154 0.6× 52 1.5k
Junichi Yano Japan 24 1.4k 0.6× 116 0.1× 208 0.6× 80 0.3× 214 0.8× 50 1.9k
Zhengxin Wang United States 32 2.3k 1.1× 355 0.4× 132 0.4× 48 0.2× 308 1.2× 71 3.2k
Frédéric Lopez France 25 1.3k 0.6× 138 0.2× 155 0.4× 168 0.6× 133 0.5× 46 2.6k
Rey-Chen Pong United States 22 1.4k 0.6× 471 0.6× 36 0.1× 149 0.5× 325 1.2× 36 2.1k
Undine Schubert Germany 8 1.2k 0.5× 210 0.3× 79 0.2× 71 0.3× 150 0.6× 14 1.5k

Countries citing papers authored by Martin L. Read

Since Specialization
Citations

This map shows the geographic impact of Martin L. Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin L. Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin L. Read more than expected).

Fields of papers citing papers by Martin L. Read

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin L. Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin L. Read. The network helps show where Martin L. Read may publish in the future.

Co-authorship network of co-authors of Martin L. Read

This figure shows the co-authorship network connecting the top 25 collaborators of Martin L. Read. A scholar is included among the top collaborators of Martin L. Read based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin L. Read. Martin L. Read is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Read, Martin L., Selvambigai Manivannan, Jana Kim, et al.. (2023). Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo. Clinical Cancer Research. 30(7). 1352–1366. 8 indexed citations
2.
Muzaffar, Jameel, et al.. (2023). The potential interaction between medical treatment and radioiodine treatment success: A systematic review. Frontiers in Endocrinology. 13. 1061555–1061555. 1 indexed citations
3.
Fletcher, Alice, Martin L. Read, Dean P. Larner, et al.. (2019). Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake. Cancer Research. 80(1). 102–115. 34 indexed citations
4.
Thompson, Rebecca, Alice Fletcher, Mohammed Merae Alshahrani, et al.. (2019). Dimerization of the Sodium/Iodide Symporter. Thyroid. 29(10). 1485–1498. 9 indexed citations
5.
Read, Martin L., Jim C. Fong, Anne Fletcher, et al.. (2017). Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. Oncogene. 36(37). 5296–5308. 21 indexed citations
6.
Mansell, Jason P., et al.. (2016). Chitinase 3-like 1 expression by human (MG63) osteoblasts in response to lysophosphatidic acid and 1,25-dihydroxyvitamin D3. Biochimie. 128-129. 193–200. 11 indexed citations
7.
Watkins, Rachel, Martin L. Read, Neil Sharma, et al.. (2016). Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin. The Journal of Clinical Endocrinology & Metabolism. 101(12). 4551–4563. 10 indexed citations
8.
Read, Martin L., Robert Seed, Neil Sharma, et al.. (2013). Regulation of Pituitary Tumor Transforming Gene (PTTG) Expression and Phosphorylation in Thyroid Cells. Endocrinology. 154(11). 4408–4422. 10 indexed citations
9.
Read, Martin L., Neil Sharma, Robert Seed, et al.. (2011). Proto-oncogene PBF/PTTG1IP Regulates Thyroid Cell Growth and Represses Radioiodide Treatment. Cancer Research. 71(19). 6153–6164. 40 indexed citations
10.
Sims, Karen, Zubair Ahmed, Martin L. Read, et al.. (2009). In vitro evaluation of a ‘stealth’ adenoviral vector for targeted gene delivery to adult mammalian neurones. The Journal of Gene Medicine. 11(4). 335–344. 7 indexed citations
11.
Ahmed, Zubair, Martin L. Read, Michael R. Douglas, et al.. (2009). Optimisation of siRNA-mediated RhoA silencing in neuronal cultures. Molecular and Cellular Neuroscience. 40(4). 451–462. 25 indexed citations
12.
Vázquez, María J., William J. Leavens, Ronggang Liu, et al.. (2008). Discovery of GSK837149A, an inhibitor of human fatty acid synthase targeting the β‐ketoacyl reductase reaction. FEBS Journal. 275(7). 1556–1567. 42 indexed citations
13.
Sims, Karen, Zubair Ahmed, Ana María Gonzalez, et al.. (2008). Targeting adenoviral transgene expression to neurons. Molecular and Cellular Neuroscience. 39(3). 411–417. 10 indexed citations
14.
Parker, Alan L., Kerry D. Fisher, David Oupický, et al.. (2005). Enhanced gene transfer activity of peptide-targeted gene-delivery vectors. Journal of drug targeting. 13(1). 39–51. 36 indexed citations
15.
Read, Martin L., et al.. (2003). Emerging Developments in RNA Therapeutics. Expert Opinion on Therapeutic Targets. 7(2). 299–303. 10 indexed citations
16.
Read, Martin L., K. Helen Bremner, David Oupický, et al.. (2003). Vectors based on reducible polycations facilitate intracellular release of nucleic acids. The Journal of Gene Medicine. 5(3). 232–245. 128 indexed citations
18.
Dash, Philip R., Martin L. Read, L B Barrett, Margreet A. Wolfert, & Leonard W. Seymour. (1999). Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Therapy. 6(4). 643–650. 309 indexed citations
19.
Macfarlane, Wendy M., Helen Cragg, Hilary M. Docherty, et al.. (1997). Impaired expression of transcription factor IUF1 in a pancreatic β‐cell line derived from a patient with persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis). FEBS Letters. 413(2). 304–308. 38 indexed citations
20.
Clark, Andrew R., et al.. (1993). Human insulin gene enhancer‐binding proteins in pancreatic α and β cell lines. FEBS Letters. 329(1-2). 139–143. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026